2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC3196 | |||||||||||||||||||||||
Submitter : | Mr. Ronald J. Reso | Date & Time: | 12/14/2006 01:12:56 | |||||||||||||||||||||
Organization : | Mr. Ronald J. Reso | |||||||||||||||||||||||
Category : | Federal Government | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Please do not allow drug companies use stem cells from aborted babies to develop vaccines or other medication. | ||||||||||||||||||||||||